| 000 | 01026 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512003502.0 | ||
| 264 | 0 | _c19890608 | |
| 008 | 198906s 0 0 eng d | ||
| 022 | _a0340-5354 | ||
| 024 | 7 |
_a10.1007/BF00314330 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilhus, N E | |
| 245 | 0 | 0 |
_aIgG subclasses in epileptic patients treated with phenytoin. _h[electronic resource] |
| 260 |
_bJournal of neurology _cMar 1989 |
||
| 300 |
_a149-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xblood |
| 650 | 0 | 4 |
_aImmunoglobulin gamma-Chains _xblood |
| 650 | 0 | 4 |
_aPhenytoin _xtherapeutic use |
| 700 | 1 | _aLea, T | |
| 773 | 0 |
_tJournal of neurology _gvol. 236 _gno. 3 _gp. 149-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00314330 _zAvailable from publisher's website |
| 999 |
_c2502202 _d2502202 |
||